Adverse reactions to cromolyn.

The frequency of adverse reactions (dermatitis, myositis, and gastroenteritis) to cromolyn sodium in asthmatic patients was 2% (B/375). Reactions were non-life-threatening and completely reversible. Immunologic evaluations, including skin and serum tests for immediate and delayed reactivity, all were negative. Adverse reactions to cromolyn do not appear to be based on an immunologic mechanism. Cromolyn appears to be a safe drug for the treatment of asthma.

[1]  J. Weltman,et al.  A galactosidase immunosorbent test for human immunoglobulin E. , 1976, The Journal of allergy and clinical immunology.

[2]  A. Sheffer,et al.  Immunologic components of hypersensitivity reactions to cromolyn sodium. , 1975, The New England journal of medicine.

[3]  G. Settipane,et al.  Aspirin intolerance. III. Subtypes, familial occurence, and cross-reactivity with tartarazine. , 1975, The Journal of allergy and clinical immunology.

[4]  I. Kass,et al.  Pulmonary allergic granulomatosis: a possible drug reaction in a patient receiving cromolyn sodium. , 1974, Chest.

[5]  G. Settipane,et al.  Aspirin intolerance: I. Frequency in an allergic population , 1974 .

[6]  D. E. Klein,et al.  Aspirin intolerance. II. A prospective study in an atopic and normal population. , 1974, The Journal of allergy and clinical immunology.

[7]  I. Machtey,et al.  Pulmonary infiltrates with eosinophilia in an asthmatic patient treated with disodium cromoglycate. , 1972, Lancet.

[8]  G. F. Moss,et al.  Plasma levels and urinary excretion of disodium cromoglycate afer inhalation by human volunteers. , 1971, Toxicology and applied pharmacology.

[9]  G. F. Moss,et al.  Distribution and metabolism of disodium cromoglycate in rats. , 1970, Toxicology and applied pharmacology.

[10]  R. Farr,et al.  A quantitative immunochemical measure of the primary interaction between I BSA and antibody. , 1958, The Journal of infectious diseases.

[11]  R. A. Kern,et al.  PENICILLIN REACTIONS: THEIR NATURE, GROWING IMPORTANCE, RECOGNITION, MANAGEMENT AND PREVENTION , 1953, The American journal of the medical sciences.

[12]  G. Rachelefsky,et al.  An action of disodium cromoglycate: inhibition of cyclic 3',5'-AMP phosphodiesterase. , 1976, The Journal of allergy and clinical immunology.